PDF file: EURASNET Annual Report 2008

collaboration between EURASNET and DCP. A contract between EURASNET andAffimetrix is being finalized.• Number of patent applicationsNone• Establishment of partnerships with a drug discovery companyNone.PUBLIC SCIENCE ACTIVITIES• EURASNET brochureAn extended format will be available by month 40.• Attendance at workshops on PSU trainingWorkshop on PSU as part of Annual Meeting Krakow 2008 (month 29) was attendedby 31 participants.• Webpage for Science and Society "site-hits"unknown• Number of lay articles publishedNoneDURABILITY• Number of additional funds used to perpetuate the networkEURASNET funding provides only a minute amount of the funds required to carryout the agreed upon Joint Program of Activities. For each participating lab the majorpart of funding therefore relies on other grants and/or institutional funding.• Number of successful joint grant applicationsCurrently statistics on such grant applications are not available, although we knowthat such successful applications exist.• Integration of the broader European RNA communityWorkshops and IFMs served as suitable tools to bring EURASNET and the broaderRNA community into close contact. In 2008 EURASNET attracted considerableattention from the medical community during workshop and IFM (London, Rome)particularly designed for promoting knowledge about alternative splicing.• Number of NoE activities sponsored by industryThe Krakow International Meeting received sponsoring from industry.GENERAL MANAGEMENT• Reports by the managers for approvalAmendment for YIP integration (2 nd round) was submitted Dec 2007 and approvedMay 2008.• Efficient information flow within NoEwas achieved through e-mails and telephone/video conferences.• Efficient execution of committee decisions22